iTeos Announces 2025 Strategic Priorities and Anticipated Milestones
Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 ...
Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer
Previously at MeiraGTx, GSK and Novartis, Dr. Leighton will help Chemify scale the company’s operational capacity to meet ...
Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference
Portfolio Receipts expected to be approximately $2,800 million, at the upper end of guidance rangeExciting development-stage pipeline with ...
TMCnet55m
Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes
SPR206 is an investigational, intravenously administered next-generation polymyxin that has shown antibiotic activity against MDR Gram-negative pathogens, including carbapenem-resistant ...
Herpes Zoster (Shingles) Global Clinical Trials Review 2024: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type And End-Point Status
( MENAFN - GlobeNewsWire - Nasdaq) Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Herpes Zoster (Shingles) - Global Clinical Trials Review, 2024" clinical trials has been added to ...